A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021

The second year of the COVID-19 pandemic had no adverse effect on the number of new drug approvals by the US Food and Drug Administration (FDA). Quite the contrary, with a total of 50 new drugs, 2021 belongs to the most successful FDA years. We assign these new drugs to one of three levels of innova...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayki-Mutlu, Gizem, Aksoyalp, Zinnet Sevval, Wojnowski, Leszek, Michel, Martin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091141/
https://www.ncbi.nlm.nih.gov/pubmed/35543739
http://dx.doi.org/10.1007/s00210-022-02250-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091141/
https://www.ncbi.nlm.nih.gov/pubmed/35543739
http://dx.doi.org/10.1007/s00210-022-02250-2

Ejemplares similares